Julie Stacey PhD 🔬

Seeking better health and medicine via #science. Editor of @eBioMedicine, published by The Lancet. Opinions my own. @[email protected]

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Kalypso Karastergiou, US Senior Editor, will be attending the 2023 IACFS/ME Medical and Scientific Conference from July 27 to July 29.

You are invited to reach out with submission enquiries.

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Are you attending #BNA2023? Our senior editor, Saleha Hassan will be there. Please reach out to her with submission enquiries.
Explore our scope, focus, impact & more https://t.co/sEQj4u7VsD

@BritishNeuro, @ParkinsonsUK, @Brain1878

[Julie Stacey PhD 🔬 @science_4tw]

@SesmaLab @camilahcoelho @IcahnMountSinai Amazing, Ana!! Congratulations 🎉!!

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

NEW study by @Kelvinkwto & coll

BNT162b2 (vs CoronaVac) and booster doses were factors independently associated with higher neutralization antibody titers

Pts with hybrid immunity had higher BA2/BA5 ab titers than those with vaccine-only immunity

Read https://t.co/9iRF5zvyUo

[Sharon Lewin @ProfSharonLewin]

Excited to publish this work demonstrating the liver is an HIV reservoir - a wonderful collaboration with colleagues in Thailand and the US @DrJenAudsley @AKashubaUNC @HIVNAT @nhmrc HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infe... https://t.co/EiODbBOkzM

[The Lancet Digital Health @LancetDigitalH]

NEW joint Series between @LancetRespirMed and
@LancetDigitalH, on digital technology and the future of interstitial lung diseases! Read more about the Series here: https://t.co/EqbFRsxvcE

#ILD #digitalhealth

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

NEW
Emerging paradigms in sepsis

This Series addresses knowledge gaps in diagnostics, disease mechanisms, therapeutics of sepsis, and provides forward-looking perspectives from
@jlvincen @DrJohnCMarshall @osuchm @CWoodsHillMD @AntcliffeDavid & more

Read https://t.co/eIJ2OnFha0

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

3rd highlight of Nov

@Glover_Tryplab @SimaNuria @BriceRotureau & coll from @institutpasteur @IbeidLabex @PIV_IP
have developed
a CRISPR based diagnostic for trypanosomes using SHERLOCK readily adaptable to a field-based setting.

Read https://t.co/EL7EPNhils

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Our November issue is now online! We will share a few highlights in the coming weeks

A lot of exciting research about #infectiousdiseases #SARSCoV2 #oncology #tremors #exercise & more

Table of contents https://t.co/yhMvsF0REZ

Register for content alert https://t.co/7EWoaSAPaq

[NEJM @NEJM]

Among school districts in the greater Boston area, the lifting of masking requirements was associated with an additional 44.9 Covid-19 cases per 1000 students and staff during the 15 weeks after a statewide masking policy was rescinded. https://t.co/CD59z7uZO0

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

In our October issue, read our editorial all about Long #COVID, and call for papers that will advance our understanding of the disease mechanisms and identify effective therapeutics
#CureARDS

Read #openaccess https://t.co/l53cCQ4kf0

[Prof. Akiko Iwasaki @VirusesImmunity]

Nasal booster with recombinant spike protein or spike mRNA in PACE converts systemic immunity induced by primary vaccines into mucosal immunity

⬇️ Infection
⬇️ Transmission
🚫 Disease

Prime and Spike is published today 👇🏽
@tianyangmao @BenIsraelow

https://t.co/3AIhNy77I1

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

You can still register for #LancetSummitAI later this week.
In addition to a great lineup of experts, you can meet and chat with editors of the Lancet group, including two eBioMedicine editors @MashbatMeg @Hannah_K_Ralph

Register at: https://t.co/7VGJqhPymL

[Wonder of Science @wonderofscience]

A rare encounter with a giant phantom jellyfish 990m (3,200 ft) beneath the surface in Monterey Bay.

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Our September issue is now online! We will share a few highlights in the coming days

Among other exciting papers, all #openaccess:
#Cancer #SARSCoV2 #obesity #Diabetes #HIV

Table of contents: https://t.co/yhMvsFit3z
Register for content alert https://t.co/7EWoaSSqz0

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Hear Raina MacIntyre @Globalbiosec on harnessing the potential of #AI for #epidemic early warning at #LancetSummitAI. View the full programme and register at https://t.co/7VGJqi79Ll #covid-19

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Our August issue is now online! Stay tuned for some highlights.

Among other exciting papers, all #openaccess:
#MultipleSclerosis #SARSCoV2 #Malaria #Diabetes #HIV

Table of contents: https://t.co/yhMvsFit3z
Register for content alert https://t.co/7EWoaSSqz0

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Our July issue is now online! Stay tuned for some highlights.

Among other exciting papers, all #openaccess:
#microbiome #SARSCoV2 #HIV #miscarriage #AirPollution #hepatitis #epilepsy

Table of contents: https://t.co/yhMvsFit3z
Register for content alert https://t.co/7EWoaSSqz0

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

We are delighted to share our Impact Factor of 11·205. We are an internationally trusted, #openaccess journal publishing essential, early evidence in biomedical research.
https://t.co/f5IH0LTNTM

[eBioMedicine – The Lancet Discovery Science @eBioMedicine]

Our UK senior editor, Dr Meg Mashbat is attending the @MDC_IoN_UCL conference in London. Please feel free to contact her to discuss potential submissions to our journal.